These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6343125)

  • 21. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
    Blume KG; Long GD; Negrin RS; Chao NJ; Kusnierz-Glaz C; Amylon MD
    Bone Marrow Transplant; 1994; 14 Suppl 4():S9-10. PubMed ID: 7728133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody therapy of lymphomas and leukemia.
    Kaminski MS; Foon KA
    Cancer Treat Res; 1988; 38():253-63. PubMed ID: 2908598
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoclonal antibodies: potential applications to the treatment of cancer.
    Houghton AN; Scheinberg DA
    Semin Oncol; 1986 Jun; 13(2):165-79. PubMed ID: 3520825
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal antibodies in cancer therapy.
    Oldham RK
    J Clin Oncol; 1983 Sep; 1(9):582-90. PubMed ID: 6366145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow transplantation. I. Use in neoplastic diseases.
    Spruce WE
    Am J Pediatr Hematol Oncol; 1983; 5(3):287-94. PubMed ID: 6353968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bone marrow transplantation for aplastic anemia and acute leukemia (author's transl)].
    Nakamura S
    Rinsho Ketsueki; 1980 Apr; 21(4):465-71. PubMed ID: 6997546
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants.
    Champlin RE; Gale RP
    Cancer Treat Rep; 1984 Jan; 68(1):145-61. PubMed ID: 6362862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of antibodies or their fragments for the treatment of tumors].
    Douillard JY; Chatal JF
    Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
    Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
    Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased intensity of acute graft-versus-host disease after reduced-intensity bone marrow transplantation compared to conventional transplantation from an HLA-matched sibling in children.
    Inoue M; Okamura T; Yasui M; Sawada A; Sakata N; Koyama M; Sakata A; Takeshita Y; Kouroki M; Yagi K; Kawa K
    Bone Marrow Transplant; 2006 Mar; 37(6):601-5. PubMed ID: 16444280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies in the treatment of human leukemias and lymphomas: applications of flow cytometry.
    Miller RA; Maloney D; Levy R
    Ann N Y Acad Sci; 1984; 428():49-56. PubMed ID: 6588910
    [No Abstract]   [Full Text] [Related]  

  • 34. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary lymphoreticular neoplasms of the digestive tract].
    Sulocka J; Kobierska A; Krajewska B
    Wiad Lek; 1975 Feb; 28(4):265-8. PubMed ID: 1114830
    [No Abstract]   [Full Text] [Related]  

  • 36. Requirements for the successful application of autologous bone marrow transplantation in the treatment of selected malignancies.
    Kaizer H; Wharam MD; Johnson RJ; Economou JG; Shin HS; Santos GW; Elfenbein GJ; Tutschka PJ; Braine HG; Munoz LL; Leventhal BG
    Haematol Blood Transfus; 1980; 25():285-96. PubMed ID: 7021346
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trial of intensive therapy and autologous bone marrow transplantation in the treatment of malignant diseases.
    Harada M; Yoshida T; Funada H; Hattori K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():543-52. PubMed ID: 6394815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
    Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
    Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical application of monoclonal antibodies].
    Yata J
    Ryumachi; 1984 Aug; 24(4):288-94. PubMed ID: 6393366
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibodies: the possibilities for cancer therapy.
    Poynton CH; Reading CL
    Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.